14:05-14:35 The role of Tyrosine Kinase Inhibitor in the adjuvant setting of HER2+ breast cancer 14:35-15:05 Solving the unmet need in HER2+ BC by Neratinib CNS 15:05-15:25 Breast cancer diagnosis with big data 15:25-15:45 Gut microbiota in premenopausal breast cancer: should we pay attention? 15:45-15:55 Break 15:55-16:35 Metastatic Breast Cancer Chemotherapy with Real World Clinical Experience 16:35-17:05 The Current Role of Chemotherapy in the combination of Metastatic Breast Cancer Treatment 17:05-17:20 Panel Discussion 17:20-17:30 Closing